NO20040319L - Sårforbinding, fremgangsmåte for fremstilling av et preparat, topisk farmasøytisk avgivelsessystem samt applikator - Google Patents

Sårforbinding, fremgangsmåte for fremstilling av et preparat, topisk farmasøytisk avgivelsessystem samt applikator

Info

Publication number: NO20040319L
Authority: NO; Norway
Prior art keywords: preparation; applicator; delivery system; wound dressing; topical pharmaceutical
Prior art date: 2001-07-24

Application number

NO20040319A

Other languages

English (en)

Other versions

NO334175B1 (no

Inventor

Alvin Berlat

Original Assignee

Advanced Bio Tech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-24

Filing date

2004-01-23

Publication date

2004-01-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23190223&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20040319(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-01-23 Application filed by Advanced Bio Tech Inc filed Critical Advanced Bio Tech Inc

2004-01-23 Publication of NO20040319L publication Critical patent/NO20040319L/no

2014-01-06 Publication of NO334175B1 publication Critical patent/NO334175B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Materials Engineering (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20040319A 2001-07-24 2004-01-23 Sårforbinding, fremgangsmåte for fremstilling av et preparat, topisk farmasøytisk avgivelsessystem samt applikator NO334175B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US30754801P	2001-07-24	2001-07-24
PCT/GB2002/003387 WO2003009877A1 (en)	2001-07-24	2002-07-23	Topical pharmaceutical formulation

Publications (2)

Publication Number	Publication Date
NO20040319L true NO20040319L (no)	2004-01-23
NO334175B1 NO334175B1 (no)	2014-01-06

Family

ID=23190223

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040319A NO334175B1 (no)	2001-07-24	2004-01-23	Sårforbinding, fremgangsmåte for fremstilling av et preparat, topisk farmasøytisk avgivelsessystem samt applikator

Country Status (20)

Country	Link
US (1)	US8263114B2 (no)
EP (1)	EP1409034B1 (no)
JP (1)	JP3778559B2 (no)
KR (1)	KR101009267B1 (no)
CN (1)	CN1234426C (no)
AT (1)	ATE331537T1 (no)
AU (1)	AU2002317981B2 (no)
BR (1)	BRPI0211282B8 (no)
CA (1)	CA2454673C (no)
DE (1)	DE60212847T2 (no)
DK (1)	DK1409034T3 (no)
ES (1)	ES2268061T3 (no)
IL (2)	IL160109A0 (no)
MX (1)	MXPA04000444A (no)
NO (1)	NO334175B1 (no)
NZ (1)	NZ529957A (no)
PT (1)	PT1409034E (no)
RU (1)	RU2306121C2 (no)
WO (1)	WO2003009877A1 (no)
ZA (1)	ZA200400488B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070237834A1 (en) *	2003-04-18	2007-10-11	Bioderm Research	Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)
CA2530811C (en) *	2003-07-03	2013-01-08	The University Court Of The University Of St Andrews	Zeolites for delivery of nitric oxide
AU2005302085B2 (en) *	2004-11-07	2011-03-17	Cupron Performance Additives, Inc.	Copper containing materials for treating wounds, burns and other skin conditions
CA2637447A1 (en) *	2006-01-30	2007-08-02	Sanjeev Kaila	A composition including a silicone-based polymer and a method of treating skin disorders using the composition
CA2692187A1 (en) *	2007-06-29	2009-01-08	Carmanah Technologies Corp.	Intelligent area lighting system
UA28103U (uk) *	2007-07-12	2007-11-26	Ольга Олександрівна Біляєва	Комплексний сорбційно-протеолітичний препарат сертасил для лікування гнійних ран, трофічних виразок, опіків
GB0821345D0 (en) *	2008-11-21	2008-12-31	P Q Silicas Uk Ltd	Composition and dressing with nitric oxide
WO2010079209A2 (en) *	2009-01-08	2010-07-15	Golub Alexandr A	Compositions for treating wounds and skin conditions
US20100322875A1 (en) *	2009-06-18	2010-12-23	Advanced Bio-Technologies, Inc.	Silicone scar treatment preparation
RU2012104912A (ru) *	2009-07-17	2013-08-27	КЕЭ-ФЬЮЖН 2200, Инк.	Частицы, содержащие противомикробные агенты
RU2429820C2 (ru) *	2009-09-24	2011-09-27	Закрытое акционерное общество "Институт прикладной нанотехнологии" (ЗАО"ИПН")	Антисептическая мазь наружного применения (2 варианта)
CN102665765A (zh) *	2009-11-03	2012-09-12	立普妥公司	促进创伤愈合的组合物
WO2011056115A1 (en)	2009-11-03	2011-05-12	Lipidor Ab	Lipid layer forming composition for administration onto a surface of a living organism
WO2011156910A2 (en) *	2010-06-17	2011-12-22	Covalon Technologies Inc.	Antimicrobial silicone-based wound dressings
WO2012150890A1 (en) *	2011-05-02	2012-11-08	Lipidor Ab	Antibacterial composition
US20130144225A1 (en)	2011-12-06	2013-06-06	Jessica Rowen	Method And Device For Scar Management
TWI474823B (zh) *	2013-09-25	2015-03-01	Far Eastern New Century Corp	疤痕凝膠的組成物
US9226890B1 (en)	2013-12-10	2016-01-05	Englewood Lab, Llc	Polysilicone base for scar treatment
US9622483B2 (en)	2014-02-19	2017-04-18	Corning Incorporated	Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039620B2 (en)	2014-02-19	2021-06-22	Corning Incorporated	Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en)	2014-02-19	2021-06-22	Corning Incorporated	Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
CN106729963A (zh) *	2016-12-22	2017-05-31	苏州迈达医疗器械有限公司	一种硅酮凝胶敷料及其生产工艺
US10496949B2 (en)	2017-01-04	2019-12-03	Christopher Zoumalan	Compositions and methods for treating cutaneous conditions
RU2674445C1 (ru) *	2017-12-11	2018-12-10	Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия имени С.М. Кирова Министерства обороны Российской Федерации (ВМедА)	Спрей для наружного применения спиртовой
CN108714141A (zh) *	2018-05-29	2018-10-30	南京华开生物科技有限公司	硅酮疤痕喷剂
WO2020019050A1 (en)	2018-07-26	2020-01-30	Exciton Pharma Corp.	Vehicles and delivery systems for oxidizing agents
WO2020061671A1 (en) *	2018-09-26	2020-04-02	Exaltexx Inc.	Winterized maturing agent, viscosity reducer and production enhancer
US11433016B2 (en)	2019-03-28	2022-09-06	L'oreal	Cosmetic compositions for skin
US11207255B2 (en)	2019-07-30	2021-12-28	L'oreal	Perfluoro-free self-foaming facial cleanser composition
US11364190B2 (en)	2019-07-30	2022-06-21	L'oreal	Acid perfluoro-free self-foaming facial cleanser composition
US12109279B2 (en)	2020-08-25	2024-10-08	L'oreal	Self-bubbling peel-away cleansing mask
US11213473B1 (en)	2020-09-18	2022-01-04	Christopher Zoumalan	Skin brightening composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5292530A (en) *	1991-06-02	1994-03-08	Helene Curtis, Inc.	Stable anhydrous topically-active composition and suspending agent therefor
US5741509A (en) *	1996-08-26	1998-04-21	Alvin S. Berlat	Silicone wound dressing

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0618899B2 (ja) *	1987-06-30	1994-03-16	品川燃料株式会社	抗菌性ゼオライト含有フィルム
JPH049327A (ja)	1990-04-04	1992-01-14	Kootec Kk	創傷被覆材
DE4034705A1 (de) *	1990-10-31	1992-05-07	Martin Neumann	Wundverschluss
FR2678513B1 (fr) *	1991-07-03	1995-06-30	Laboratoires Hygiene Dietetique	Pansement cicatrisant.
WO1997003710A1 (en)	1995-07-19	1997-02-06	Innovative Technologies Limited	Wound treatment composition
US5833998A (en)	1995-11-06	1998-11-10	The Procter & Gamble Company	Topical compositions for regulating the oily/shiny appearance of skin
JPH09194350A (ja)	1996-01-19	1997-07-29	Morishita Jintan Kk	創傷被覆材
US6231259B1 (en)	1996-07-26	2001-05-15	The Gillette Company	Viscous product dispenser with porous dome
AU1923199A (en) *	1997-12-17	1999-07-05	Hemodynamics, Inc.	Sealing media for surgery and wound closure
JP2002536397A (ja)	1999-02-12	2002-10-29	ザ、プロクター、エンド、ギャンブル、カンパニー	皮膚消毒剤組成物
US6183766B1 (en)	1999-02-12	2001-02-06	The Procter & Gamble Company	Skin sanitizing compositions
GB0007140D0 (en)	1999-09-27	2000-05-17	Dow Corning Sa	Scar treatment composition
MXPA02011440A (es) *	2000-05-23	2003-04-25	Unilever Nv	Composiciones desodorantes y/o antitranspirantes.
US8486374B2 (en)	2003-08-04	2013-07-16	Foamix Ltd.	Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20060110415A1 (en)	2004-11-22	2006-05-25	Bioderm Research	Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20080292560A1 (en)	2007-01-12	2008-11-27	Dov Tamarkin	Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
PT2211919E (pt)	2007-09-30	2011-12-05	Meda Ab	Composições à base de gel de silicone para cicatrização de ferimentos e redução de cicatriz

2002
- 2002-07-23 DK DK02747591T patent/DK1409034T3/da active
- 2002-07-23 JP JP2003515269A patent/JP3778559B2/ja not_active Expired - Lifetime
- 2002-07-23 MX MXPA04000444A patent/MXPA04000444A/es active IP Right Grant
- 2002-07-23 CA CA2454673A patent/CA2454673C/en not_active Expired - Lifetime
- 2002-07-23 EP EP02747591A patent/EP1409034B1/en not_active Expired - Lifetime
- 2002-07-23 NZ NZ529957A patent/NZ529957A/en not_active IP Right Cessation
- 2002-07-23 ES ES02747591T patent/ES2268061T3/es not_active Expired - Lifetime
- 2002-07-23 RU RU2004105164/15A patent/RU2306121C2/ru active
- 2002-07-23 AU AU2002317981A patent/AU2002317981B2/en not_active Expired
- 2002-07-23 WO PCT/GB2002/003387 patent/WO2003009877A1/en not_active Ceased
- 2002-07-23 CN CNB028140214A patent/CN1234426C/zh not_active Expired - Lifetime
- 2002-07-23 AT AT02747591T patent/ATE331537T1/de active
- 2002-07-23 BR BRPI0211282A patent/BRPI0211282B8/pt not_active IP Right Cessation
- 2002-07-23 KR KR1020047001045A patent/KR101009267B1/ko not_active Expired - Lifetime
- 2002-07-23 US US10/480,719 patent/US8263114B2/en active Active
- 2002-07-23 IL IL16010902A patent/IL160109A0/xx active IP Right Grant
- 2002-07-23 PT PT02747591T patent/PT1409034E/pt unknown
- 2002-07-23 DE DE60212847T patent/DE60212847T2/de not_active Expired - Lifetime
2004
- 2004-01-22 ZA ZA2004/00488A patent/ZA200400488B/en unknown
- 2004-01-23 NO NO20040319A patent/NO334175B1/no not_active IP Right Cessation
- 2004-01-28 IL IL160109A patent/IL160109A/en unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5292530A (en) *	1991-06-02	1994-03-08	Helene Curtis, Inc.	Stable anhydrous topically-active composition and suspending agent therefor
US5741509A (en) *	1996-08-26	1998-04-21	Alvin S. Berlat	Silicone wound dressing

Also Published As

Publication number	Publication date
ZA200400488B (en)	2005-06-29
IL160109A0 (en)	2004-06-20
EP1409034B1 (en)	2006-06-28
DK1409034T3 (da)	2006-10-30
KR101009267B1 (ko)	2011-01-18
CN1527729A (zh)	2004-09-08
JP2005502639A (ja)	2005-01-27
ES2268061T3 (es)	2007-03-16
WO2003009877A1 (en)	2003-02-06
RU2306121C2 (ru)	2007-09-20
AU2002317981B2 (en)	2006-12-07
MXPA04000444A (es)	2004-10-27
BR0211282B1 (pt)	2018-01-09
NZ529957A (en)	2005-11-25
PT1409034E (pt)	2006-11-30
US20040234474A1 (en)	2004-11-25
EP1409034A1 (en)	2004-04-21
CN1234426C (zh)	2006-01-04
BR0211282A (pt)	2004-08-03
KR20040032864A (ko)	2004-04-17
ATE331537T1 (de)	2006-07-15
DE60212847T2 (de)	2007-06-14
RU2004105164A (ru)	2005-06-27
HK1061362A1 (en)	2004-09-17
CA2454673C (en)	2011-04-26
IL160109A (en)	2008-04-13
US8263114B2 (en)	2012-09-11
DE60212847D1 (de)	2006-08-10
BRPI0211282B8 (pt)	2021-05-25
NO334175B1 (no)	2014-01-06
JP3778559B2 (ja)	2006-05-24
CA2454673A1 (en)	2003-02-06

Publication	Publication Date	Title
NO20040319L (no)	2004-01-23	Sårforbinding, fremgangsmåte for fremstilling av et preparat, topisk farmasøytisk avgivelsessystem samt applikator
MXPA02011722A (es)	2003-10-14	Composicion y aplicador para suministro de sustancias topicas.
EE200200535A (et)	2004-04-15	Konjugeeritud östrogeenide ja medroksüprogesteroonatsetaadi kasutamine, farmatseutiline kompositsioon, doseerimisühik ja pakend
DK1304992T3 (da)	2009-08-10	Topisk gel-fremföringssystem til behandling af hudlidelser
DE60212163D1 (de)	2006-07-20	Kontrolliertes wirkstoffabgabesystem
ID27504A (id)	2001-04-12	Formulasi oral baru
ATE391496T1 (de)	2008-04-15	Geschmacksmaskierte pharmazeutische formulierungen
WO2002098482A3 (en)	2003-05-08	System for osmotic delivery of pharmaceutically active agents
DK1059934T3 (da)	2002-11-11	Matrixproteinpræparater til sårheling
PT1361903E (pt)	2005-01-31	Penso para feridas
DK1033990T3 (da)	2002-07-08	21-Hydroxy-6,19-oxidoprogesteron (21OH-6OP) dets anvendelse som medikament i behandling af glucocorticoidoverskud
NO20022525L (no)	2002-05-28	Farmasöytiske formuleringer inneholdende zolmitriptan
ATE240717T1 (de)	2003-06-15	Wässrige formulierung zur nasalen verabreichung
DK1345595T3 (da)	2007-09-10	Ionstyrke-uafhængig farmaceutisk formulering med depotfrigivelse
WO2004052345A8 (en)	2004-08-26	Coating composition for taste masking coating and methods for their application and use
YU16399A (sh)	2000-03-21	) UPOTREBA INHIBITOR H +, K+ - ATP- aze I FARMACEUTSKA FORMULACIJA ZA SIMULTANU, SEPARATNU ILI SEKVENCIJALNU UPOTREBU, KOJA SADRZI INHIBITOR H +, K+-ATP- aze I GLUKOKORTIKOID INHIBITOR H +, K+- ATP- aze
EE05415B1 (et)	2011-06-15	Ravimi manustamise vahend, eriti androgeenide manustamiseks
ATE550073T1 (de)	2012-04-15	Protein c für die wundheilung
DE60207606D1 (de)	2005-12-29	Artikel zur wundbehandlung
NO20031650D0 (no)	2003-04-10	Nye legemidler for leversykdommer
WO1999056724A3 (de)	2000-02-17	Therapeutisches system zur topischen oder transmucosalen applikation wenigstens eines pflege- oder wirkstoffs auf bzw. durch die nasenschleimhaut sowie verfahren zur applikation des systems
AU2001262467A1 (en)	2002-01-30	Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence
AU2002302684A1 (en)	2002-10-21	Film-forming composition for topical use and use thereof for delivering active agents
FI19992648A7 (fi)	2000-02-03	Lääkkeen luovutuslaitteita ja menetelmiä virus- ja mikrobi-infektioiden ja riutumissyndrooman hoitoon
BR0205625C1 (pt)	2004-10-19	Formulações nasais em gel

Legal Events

Date	Code	Title	Description
2018-06-04	CREP	Change of representative	Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO
2022-08-15	MK1K	Patent expired